Literature DB >> 3654589

Structural comparison of bovine erythrocyte, brain, and liver NADH-cytochrome b5 reductase by HPLC mapping.

M Tamura1, T Yubisui, M Takeshita, S Kawabata, T Miyata, S Iwanaga.   

Abstract

NADH-cytochrome b5 reductases purified from bovine erythrocytes and from bovine brain and liver microsomes solubilized with lysosomal protease were subjected to structural analysis by using HPLC mapping, amino acid analysis of the resulting peptides, and NH2-terminal sequence analysis of apoproteins. HPLC maps of the tryptic peptides derived from these enzymes were very similar to each other, and amino acid analysis of the HPLC-separated peptides indicated that the structures of these enzymes are identical except for the NH2-terminal region. The NH2-terminal sequence of the brain enzyme determined by automated Edman degradation was as follows: NH2-Phe-Gln-Arg-Ser-Thr-Pro-Ala-Ile-Thr-Leu-Glu-Asn-Pro-Asp- Ile-Lys-Tyr-Pro-Leu-Arg-Leu-Ile-Asp-Lys-Glu-Val-Ile- This sequence is identical to that of liver enzyme except that the liver enzyme started at the 3rd Arg or 4th Ser. The NH2-terminal amino acid residue of the soluble erythrocyte enzyme was not detected by automated Edman degradation. The sequence analysis of a tryptic peptide from the erythrocyte enzyme indicated that Leu is present before the NH2-terminal Phe of the brain enzyme. The recently reported sequence of the apparently identical protein (Ozols et al. (1985) J. Biol. Chem. 260, 11953-11961) differs in two amino acid assignments from our sequence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654589     DOI: 10.1093/oxfordjournals.jbchem.a121979

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Two transcripts encode rat cytochrome b5 reductase.

Authors:  G Pietrini; P Carrera; N Borgese
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

2.  The opposite effect of bivalent cations on cytochrome b5 reduction by NADH:cytochrome b5 reductase and NADPH:cytochrome c reductase.

Authors:  M Tamura; T Yubisui; M Takeshita
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

3.  Severe neurological impairment in hereditary methaemoglobinaemia type 2.

Authors:  Sandra P Toelle; Eugen Boltshauser; Ekkehard Mössner; Karin Zurbriggen; Stefan Eber
Journal:  Eur J Pediatr       Date:  2004-02-18       Impact factor: 3.183

4.  A single mRNA, transcribed from an alternative, erythroid-specific, promoter, codes for two non-myristylated forms of NADH-cytochrome b5 reductase.

Authors:  G Pietrini; D Aggujaro; P Carrera; J Malyszko; A Vitale; N Borgese
Journal:  J Cell Biol       Date:  1992-06       Impact factor: 10.539

5.  Methemoglobin Modulation as an Intravascular Contrast Agent for Magnetic Resonance Imaging: Proof of Concept.

Authors:  J Scott McNally; Jared A Jaffey; Seong-Eun Kim; Matthew D Alexander; Kate L Shumway; Leah A Cohn; Dennis L Parker; Ronald W Day
Journal:  Front Vet Sci       Date:  2019-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.